Tempus AI (TEM) Revenue Outlook Boosted by Morgan Stanley Insight
Published on · Source: finance.yahoo.com
AI Summary
Summarized by AI from the source belowTempus AI (TEM) shares rose 30% this week after Morgan Stanley highlighted reimbursement pricing that may add between $330 million and $400 million in annual revenue from xT and xF diagnostics. CEO Eric Lefkofsky indicated that xT pricing could contribute $80 million to $100 million next year, while xF could contribute $250 million to $300 million. The company also raised its full-year revenue guidance to between $1.595 billion and $1.605 billion, reflecting approximately 25% annual growth. For investors, the revenue adjustments signify potential growth and a more favorable earnings trajectory moving forward.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
About Morgan Stanley (MS)
Morgan Stanley is a leading global investment bank and wealth manager.
The Financials sector covers banks, insurers and capital-markets firms at the center of the economy.
Earlier MS news
- EMCOR Growth Driven by AI Data Centers at Morgan Stanley Conference
- Lockheed Martin (LMT) Mission Shift Discussion at Morgan Stanley Conference
- American Airlines (AAL) Shows Revenue Strength at Laguna Conference
- Bruker (BRKR) Focuses on Post-Genomic Growth at Morgan Stanley Conference
- GE Vernova Backlog Surges at Morgan Stanley Conference
Understand this kind of story
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
